Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Centers for Disease Control and Prevention (CDC) in the US has reported the first case of the new coronavirus, named 2019-nCoV, in a man who returned from Wuhan city of China to Washington.

The US patient returned to the country on 15 January, with infection confirmation taking place on 21 January. The patient is assumed to be relatively healthy, now isolated at a medical centre as a precaution.

Following the report, the Dow and broader stock market saw a drop in the stock.

While the risk to the general public is low, US officials have been preparing to address a potential outbreak in the country.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

In addition to alerting clinicians and screening at airports, CDC is developing a diagnostic test to identify the virus in clinical specimens. The organisation intends to share the tests to partners globally in the coming weeks.

On 16 January, the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin researchers announced the development of the first diagnostic assay to detect the virus. The laboratory test has been made publicly available and is in a joint evaluation study by an international consortium.

Coronavirus symptoms are similar to those caused by flu, such as pneumonia. The virus has been linked to a seafood market in Wuhan, where the outbreak began. Death toll from the virus has increased to nine as of 21 January, said Chinese officials.

Alongside China, cases of the new coronavirus have been reported in Thailand, Japan and Korea. On 21 January, Taiwan reported the first case of coronavirus infection in a woman who returned from Wuhan.

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
NorthWest EHealth has won three 2025 Pharmaceutical Technology Excellence Awards for Innovation, Safety and Diversity. Explore how its ConneXon platform is transforming SAE reporting and real-time safety oversight, while FARSITE delivers socio-economically inclusive recruitment to boost trial efficiency, data integrity and regulatory-grade representativeness.

Discover the Impact